[1]
Kaloyannidis, P., Al Shaibani, E., Moinnudin, A., Al Anezi, K. and Al Hashmi, H. 2021. Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach. Hematology Reports. 13, 1 (Mar. 2021). DOI:https://doi.org/10.4081/hr.2021.8780.